photo of Prof David Burgner

Prof David Burgner

Prof David Burgner

Details

Role Group Leader / Principal Research Fellow
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.

Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.

Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.

Top Publications

  • Bekkering, S, Saner, C, Novakovic, B, Mansell, T, Longmore, DK, McCallum, Z, Ponsonby, A-L, Juonala, M, Netea, MG, Sabin, MA, et al. Increased innate immune responses in adolescents with obesity and its relation to subclinical cardiovascular measures: An exploratory study.. iScience 27(5) : 109762 2024
    view publication
  • Shepherd, R, Angus, LM, Mansell, T, Arman, B, Kim, BW, Lange, K, Burgner, D, Kerr, JA, Pang, K, Zajac, JD, et al. Impact of Distinct Anti-Androgen Exposures on the Plasma Metabolome in Feminizing Gender-Affirming Hormone Therapy.. J Clin Endocrinol Metab 2024
    view publication
  • Crick, DCP, Khandaker, GM, Halligan, SL, Burgner, D, Mansell, T, Fraser, A. Comparison of the stability of glycoprotein acetyls and high sensitivity C-reactive protein as markers of chronic inflammation.. Immunology 171(4) : 497 -512 2024
    view publication
  • Kerr, JA, Dumuid, D, Downes, M, Lange, K, O'Connor, M, Stanford, T, Thornton, L, Burgner, D, Wake, M. 6. Hypothetical Impact of Intervening on Socioeconomic Disadvantage in Childhood to Reduce the Risk of Adolescent Obesity: Stratification by Polygenic Risk in a Population Cohort Study. Journal of Adolescent Health 74(3) : s4 2024
    view publication
  • Pihlman, J, Nuotio, J, Rovio, S, Pahkala, K, Ruohonen, S, Jokinen, E, Laitinen, TP, Burgner, DP, Hutri-Kähönen, N, Tossavainen, P, et al. Exposure to parental smoking and cardiac structure and function in adulthood: the Cardiovascular Risk in Young Finns Study.. Scand J Public Health 52(1) : 15 -23 2024
    view publication

Career information